Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Format: Clinical Tool
Patients who choose to use Medications for Opioid Use Disorder (MOUD) for opioid addiction have a choice of medications.[1] One type of MOUD involve the use of an “opioid agonist.” An opioid agonist binds to the same receptors in the brain that were activated by the drug of abuse, but in a safer and more controlled manner. These medications can reduce the symptoms of withdrawal and reduce cravings, allowing for a more gradual, controlled recovery process and reducing the risk of relapse. The two opioid agonists used in MOUD are methadone and buprenorphine. Another type of medication called an “opioid antagonist” is a newer form of treatment that will also be discussed. Naltrexone is the only opioid antagonist currently available for treatment.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Podcast
Tim Brennan is director of the Addiction Institute at Mount Sinai West and Mount Sinai St. Luke’s hospitals. He discusses the why and how of transitioning a patient from methadone to buprenorphine, and dispels some common misperceptions that patients and providers have about these treatments.
Presenter(s):
Tim Brennan
Credit Available:
CE Credit(s): No
Certificate: No
Format: Video
Dr. Edwin Salsitz, a Providers Clinical Support System Clinical expert, speaks to a patient who has been on buprenorphine and has done well and now wants to taper off buprenorphine. They discuss the pros and cons of stopping the medication and what to expect.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Video
Dr. John Mariani, a Providers Clinical Support System Clinical expert, discusses with a patient about buprenorphine to treat a patient’s heroin addiction with a patient.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Video
Dr. John Mariani, a Providers Clinical Support System Clinical expert, gives a patient an idea of how she will feel once she begins taking buprenorphine for the treatment of opioid use disorder.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Video
Dr. John Mariani, a Providers Clinical Support System Clinical expert, answers a patient’s question about how long she will have to take buprenorphine to treat her heroin addiction.
Credit Available:
CE Credit(s): No
Certificate: No